Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1979
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 2
1980 3
1981 9
1982 5
1983 6
1984 4
1985 11
1986 6
1987 8
1988 13
1989 33
1990 20
1991 25
1992 29
1993 22
1994 36
1995 35
1996 43
1997 52
1998 43
1999 46
2000 47
2001 52
2002 90
2003 113
2004 131
2005 141
2006 170
2007 192
2008 264
2009 235
2010 274
2011 379
2012 433
2013 484
2014 529
2015 615
2016 737
2017 774
2018 840
2019 941
2020 1109
2021 1279
2022 1426
2023 1417
2024 1598
2025 92

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

13,276 results

Results by year

Filters applied: . Clear all
Page 1
Dietary sources, health benefits, and risks of caffeine.
Saimaiti A, Zhou DD, Li J, Xiong RG, Gan RY, Huang SY, Shang A, Zhao CN, Li HY, Li HB. Saimaiti A, et al. Among authors: zhou dd. Crit Rev Food Sci Nutr. 2023;63(29):9648-9666. doi: 10.1080/10408398.2022.2074362. Epub 2022 May 16. Crit Rev Food Sci Nutr. 2023. PMID: 35574653 Review.
Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial.
Wang H, Mao L, Yang M, Qian P, Lu H, Tong H, Xie W, Zhou D, Huang X, Wang Y, Xu G, Lu Y, Wei J, Mai W, Ye X, Meng H, Shen Y, Huang J, Yu W, Sun J, Sheng J, Yan X, Jin J, Zhu HH. Wang H, et al. Among authors: zhou d. Lancet Haematol. 2022 Jun;9(6):e415-e424. doi: 10.1016/S2352-3026(22)00106-5. Epub 2022 May 2. Lancet Haematol. 2022. PMID: 35512726 Clinical Trial.
13,276 results
You have reached the last available page of results. Please see the User Guide for more information.